Who
Marwan Sabbagh
Director
Company insider
Files Form 4 as: Director, CervoMed; Director, IRulya Therapeutics.
In numbers
- Trades disclosed
- 6
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 14 Mar 2022
- Last trade
- 8 Jun 2026
- Last filed
- 10 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 8 Jun 2026filed 10 Jun 2026 | CRVO CervoMedoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,150 at $0.00 | filing |
| 8 Jun 2026filed 10 Jun 2026 | CRVO CervoMedoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,150 at $0.00 | filing |
| 23 Jun 2025filed 25 Jun 2025 | CRVO CervoMedoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,100 at $0.00 | filing |
| 14 Jun 2024filed 14 Jun 2024 | CRVO CervoMedoption or derivative · Biotechnology | SEC FORM 4 Code A | —5,750 at $0.00 | filing |
| 15 Sep 2023filed 15 Sep 2023 | CRVO CervoMedoption or derivative · Biotechnology | SEC FORM 4 Code A | —6,450 at $0.00 | filing |
| 14 Mar 2022filed 16 Mar 2022 | IRLA IRulya Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,058 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.